Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

HealthEquity (HQY)

Nasdaq Health Care Managed Health Care S&P MidCap 400
$103.63
+0.17 (+0.16%)
Close of Nov 06, 2026 · end-of-day data
Source: HealthEquity's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$178.37M$229.53M$287.24M$531.99M$733.57M$756.56M$861.75M$999.59M$1.20B$1.31B
Cost of revenue$72.02M$94.61M$106.05M$206.08M$318.24M$331.79M$369.81M$376.95M$422.51M$400.31M
Gross profit$106.36M$134.92M$181.19M$325.91M$415.33M$424.76M$491.94M$622.64M$777.26M$913.12M
Research & development$22.38M$27.39M$35.06M$77.58M$124.81M$157.36M$193.38M$218.81M$239.51M$262.51M
Operating income$41.21M$54.42M$77.67M$77.01M$34.01M-$24.24M$9.06M$117.70M$162.33M$322.46M
Interest expense—$274.00K$270.00K$24.77M$34.88M$36.57M$48.42M$55.45M$60.63M$57.13M
Pre-tax income$40.12M$52.19M$75.82M$43.16M$4.14M-$66.74M-$38.10M$75.04M$116.03M$277.43M
Income tax$13.74M$4.83M$1.92M$3.49M-$4.69M-$22.45M-$11.95M$19.33M$19.33M$62.23M
Net income$26.38M$47.36M$73.90M$39.66M$8.83M-$44.29M-$26.14M$55.71M$96.70M$215.20M
EBITDA$54.40M$70.37M$95.86M$132.36M$149.92M$112.95M$170.26M$270.78M$324.79M$477.11M
EPS (basic)$0.45$0.79$1.20$0.59$0.12$-0.53$-0.31$0.65$1.11$2.50
EPS (diluted)$0.44$0.77$1.17$0.58$0.12$-0.53$-0.31$0.64$1.09$2.46
Diluted shares59.89M61.85M63.37M68.45M75.68M83.13M84.44M86.96M88.83M87.47M
Gross margin59.6%58.8%63.1%61.3%56.6%56.1%57.1%62.3%64.8%69.5%
Operating margin23.1%23.7%27.0%14.5%4.6%-3.2%1.1%11.8%13.5%24.6%
Net margin14.8%20.6%25.7%7.5%1.2%-5.9%-3.0%5.6%8.1%16.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$139.95M$199.47M$361.48M$191.73M$328.80M$225.41M$254.27M$403.98M$295.95M$318.93M
Receivables$17.00M$21.60M$25.67M$70.86M$72.77M$87.43M$96.83M$104.89M$118.01M$123.70M
Inventory$592.00K$215.00K————————
Total current assets$200.82M$265.40M$394.68M$297.30M$460.18M$351.34M$382.89M$557.44M$477.75M$512.28M
Goodwill$4.65M$4.65M$4.65M$1.33B$1.33B$1.65B$1.65B$1.65B$1.65B$1.65B
Total assets$279.14M$369.16M$510.02M$2.56B$2.71B$3.11B$3.09B$3.16B$3.45B$3.38B
Total current liabilities$15.70M$20.49M$29.05M$151.94M$204.70M$153.19M$131.06M$117.09M$156.32M$156.85M
Short-term debt——$0$39.06M$62.50M$8.75M$17.50M$0$0$0
Long-term debt——$0$1.18B$924.22M$922.08M$907.84M$874.97M$1.06B$957.38M
Total debt——$0$1.22B$986.72M$930.83M$925.34M$874.97M$1.06B$957.38M
Total liabilities$17.20M$22.89M$32.94M$1.53B$1.33B$1.25B$1.19B$1.13B$1.33B$1.27B
Shareholders' equity$261.94M$346.27M$477.08M$1.03B$1.38B$1.85B$1.90B$2.04B$2.11B$2.11B

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$45.59M$81.70M$113.42M$105.01M$181.62M$141.00M$150.65M$242.83M$339.86M$457.09M
Capital expenditures$3.65M$5.46M$3.87M$7.29M$13.09M$8.91M$3.37M$1.69M$2.08M$1.97M
Free cash flow$41.95M$76.24M$109.55M$97.72M$168.53M$132.09M$147.28M$241.13M$337.77M$455.12M
Investing cash flow-$13.05M-$36.75M$25.65M-$1.74B-$96.96M-$639.25M-$119.13M-$46.07M-$505.45M-$47.14M
Financing cash flow$23.78M$14.56M$22.93M$1.47B$52.42M$394.86M-$2.67M-$47.04M$57.57M-$386.98M
Dividends paid$0—————————
Share buybacks——————$0$0$121.49M$299.25M
Stock-based compensation$8.40M$14.31M$21.06M$39.84M$42.86M$52.75M$62.61M$77.15M$96.42M$73.06M
Depreciation & amortization$13.19M$15.95M$18.18M$55.35M$115.90M$137.19M$161.20M$153.08M$162.45M$154.66M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.